 | JFP | Name: | N-(4-methyl-1,3-thiazol-2-yl)propanamide | Formula: | C7 H10 N2 O S | SMILES: | CCC(=O)Nc1nc(cs1)C | InChi: | InChI=1S/C7H10N2OS/c1-3-6(10)9-7-8-5(2)4-11-7/h4H,3H2,1-2H3,(H,8,9,10) | Definition date: | 2018-09-10 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | N-(4-methyl-1,3-thiazol-2-yl)propanamide |
|
 | JFY | Name: | N-{4-[(2S)-butan-2-yl]phenyl}methanesulfonamide | Formula: | C11 H17 N O2 S | SMILES: | c1c(C(CC)C)ccc(c1)NS(C)(=O)=O | InChi: | InChI=1S/C11H17NO2S/c1-4-9(2)10-5-7-11(8-6-10)12-15(3,13)14/h5-9,12H,4H2,1-3H3/t9-/m0/s1 | Definition date: | 2018-09-10 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | N-{4-[(2S)-butan-2-yl]phenyl}methanesulfonamide |
|
 | JG4 | Name: | 2-(thiophen-2-yl)-1H-imidazole | Formula: | C7 H6 N2 S | SMILES: | c2cc(c1nccn1)sc2 | InChi: | InChI=1S/C7H6N2S/c1-2-6(10-5-1)7-8-3-4-9-7/h1-5H,(H,8,9) | Definition date: | 2018-09-10 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | 2-(thiophen-2-yl)-1H-imidazole |
|
 | JGA | Name: | N-ethyl-N'-(5-methyl-1,2-oxazol-3-yl)urea | Formula: | C7 H11 N3 O2 | SMILES: | CCNC(=O)Nc1noc(c1)C | InChi: | InChI=1S/C7H11N3O2/c1-3-8-7(11)9-6-4-5(2)12-10-6/h4H,3H2,1-2H3,(H2,8,9,10,11) | Definition date: | 2018-09-10 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | N-ethyl-N'-(5-methyl-1,2-oxazol-3-yl)urea |
|
 | JGD | Name: | N,N-dimethylpyridin-4-amine | Formula: | C7 H10 N2 | SMILES: | CN(c1ccncc1)C | InChi: | InChI=1S/C7H10N2/c1-9(2)7-3-5-8-6-4-7/h3-6H,1-2H3 | Definition date: | 2018-09-10 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | N,N-dimethylpyridin-4-amine |
|
 | JGG | Name: | N-[(4-cyanophenyl)methyl]morpholine-4-carboxamide | Formula: | C13 H15 N3 O2 | SMILES: | C2CN(C(NCc1ccc(C#N)cc1)=O)CCO2 | InChi: | InChI=1S/C13H15N3O2/c14-9-11-1-3-12(4-2-11)10-15-13(17)16-5-7-18-8-6-16/h1-4H,5-8,10H2,(H,15,17) | Definition date: | 2018-09-10 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | N-[(4-cyanophenyl)methyl]morpholine-4-carboxamide |
|
 | JGJ | Name: | 2-methoxy-N-[(1R)-1-phenylethyl]acetamide | Formula: | C11 H15 N O2 | SMILES: | C(NC(C)c1ccccc1)(=O)COC | InChi: | InChI=1S/C11H15NO2/c1-9(12-11(13)8-14-2)10-6-4-3-5-7-10/h3-7,9H,8H2,1-2H3,(H,12,13)/t9-/m1/s1 | Definition date: | 2018-09-10 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | 2-methoxy-N-[(1R)-1-phenylethyl]acetamide |
|
 | JGM | Name: | {N}-[(2~{S})-1-diazanyl-3-(4-hydroxyphenyl)-1-oxidanylidene-propan-2-yl]ethanamide | Formula: | C11 H15 N3 O3 | SMILES: | c1(ccc(CC(NC(C)=O)C(=O)NN)cc1)O | InChi: | InChI=1S/C11H15N3O3/c1-7(15)13-10(11(17)14-12)6-8-2-4-9(16)5-3-8/h2-5,10,16H,6,12H2,1H3,(H,13,15)(H,14,17)/t10-/m0/s1 | Definition date: | 2018-09-10 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | N-[(2S)-1-hydrazinyl-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]acetamide (non-preferred name) |
|
 | JGP | Name: | (azepan-1-yl)(2H-1,3-benzodioxol-5-yl)methanone | Formula: | C14 H17 N O3 | SMILES: | C1N(CCCCC1)C(c3ccc2OCOc2c3)=O | InChi: | InChI=1S/C14H17NO3/c16-14(15-7-3-1-2-4-8-15)11-5-6-12-13(9-11)18-10-17-12/h5-6,9H,1-4,7-8,10H2 | Definition date: | 2018-09-10 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | (azepan-1-yl)(2H-1,3-benzodioxol-5-yl)methanone |
|
 | JGS | Name: | 3-[(1,2-oxazole-5-carbonyl)amino]benzoic acid | Formula: | C11 H8 N2 O4 | SMILES: | c1(oncc1)C(Nc2cc(C(O)=O)ccc2)=O | InChi: | InChI=1S/C11H8N2O4/c14-10(9-4-5-12-17-9)13-8-3-1-2-7(6-8)11(15)16/h1-6H,(H,13,14)(H,15,16) | Definition date: | 2018-09-10 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | 3-[(1,2-oxazole-5-carbonyl)amino]benzoic acid |
|
 | JGV | Name: | (2,3-dihydro-1,2,3-benzothiadiazol-5-yl)(morpholin-4-yl)methanone | Formula: | C11 H13 N3 O2 S | SMILES: | C3N(C(c1ccc2c(c1)NNS2)=O)CCOC3 | InChi: | InChI=1S/C11H13N3O2S/c15-11(14-3-5-16-6-4-14)8-1-2-10-9(7-8)12-13-17-10/h1-2,7,12-13H,3-6H2 | Definition date: | 2018-09-10 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | (2,3-dihydro-1,2,3-benzothiadiazol-5-yl)(morpholin-4-yl)methanone |
|
 | JGY | Name: | 1-methyl-N-{[(2S)-oxolan-2-yl]methyl}-1H-pyrazole-3-carboxamide | Formula: | C10 H15 N3 O2 | SMILES: | C(C1CCCO1)NC(c2ccn(C)n2)=O | InChi: | InChI=1S/C10H15N3O2/c1-13-5-4-9(12-13)10(14)11-7-8-3-2-6-15-8/h4-5,8H,2-3,6-7H2,1H3,(H,11,14)/t8-/m0/s1 | Definition date: | 2018-09-10 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | 1-methyl-N-{[(2S)-oxolan-2-yl]methyl}-1H-pyrazole-3-carboxamide |
|
 | JH7 | Name: | 1-methyl-5-(phenylamino)-1,2-dihydro-3H-pyrazol-3-one | Formula: | C10 H11 N3 O | SMILES: | c2c(NC=1N(C)NC(C=1)=O)cccc2 | InChi: | InChI=1S/C10H11N3O/c1-13-9(7-10(14)12-13)11-8-5-3-2-4-6-8/h2-7,11H,1H3,(H,12,14) | Definition date: | 2018-09-10 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | 1-methyl-5-(phenylamino)-1,2-dihydro-3H-pyrazol-3-one |
|
 | JHA | Name: | 3-chloro-4-(4-methylpiperidin-1-yl)aniline | Formula: | C12 H17 Cl N2 | SMILES: | c1cc(c(cc1N)Cl)N2CCC(C)CC2 | InChi: | InChI=1S/C12H17ClN2/c1-9-4-6-15(7-5-9)12-3-2-10(14)8-11(12)13/h2-3,8-9H,4-7,14H2,1H3 | Definition date: | 2018-09-10 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | 3-chloro-4-(4-methylpiperidin-1-yl)aniline |
|
 | JHD | Name: | 1-(3,4-dimethoxyphenyl)methanamine | Formula: | C9 H13 N O2 | SMILES: | COc1c(OC)ccc(CN)c1 | InChi: | InChI=1S/C9H13NO2/c1-11-8-4-3-7(6-10)5-9(8)12-2/h3-5H,6,10H2,1-2H3 | Definition date: | 2018-09-10 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | 1-(3,4-dimethoxyphenyl)methanamine |
|
 | B4T | Name: | mono-PEGylated sulfonatocalix[4]arene | Formula: | C63 H94 O33 S4 | SMILES: | O=S(O)(=O)c1cc3c(c(c1)Cc2cc(cc(c2O)Cc5c(c(Cc4c(c(C3)cc(S(=O)(O)=O)c4)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc(S(O)(=O)=O)c5)O)S(O)(=O)=O)O | InChi: | InChI=1S/C63H94O33S4/c1-79-2-3-80-4-5-81-6-7-82-8-9-83-10-11-84-12-13-85-14-15-86-16-17-87-18-19-88-20-21-89-22-23-90-24-25-91-26-27-92-28-29-93-30-31-94-32-33-95-34-35-96-63-54-38-52-44-57(98(70,71)72)42-50(61(52)65)36-48-40-56(97(67,68)69)41-49(60(48)64)37-51-43-58(99(73,74)75)45-53(62(51)66)39-55(63)47-59(46-54)100(76,77)78/h40-47,64-66H,2-39H2,1H3,(H,67,68,69)(H,70,71,72)(H,73,74,75)(H,76,77,78) | Definition date: | 2017-09-14 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | 25-[(2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-heptadecaoxadopentacontan-52-yl)oxy]-26,27,28-trihydroxypentacyclo[19.3.1.1~3,7~.1~9,13~.1~15,19~]octacosa-1(25),3(28),4,6,9(27),10,12,15(26),16,18,21,23-dodecaene-5,11,17,23-tetrasulfonic acid |
|
 | B4X | Name: | di-PEGylated sulfonatocalix[4]arene | Formula: | C82 H132 O42 S4 | SMILES: | COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOc1c2Cc3cc(cc(Cc4cc(cc(Cc5cc(cc(Cc1cc(c2)[S](O)(=O)=O)c5O)[S](O)(=O)=O)c4OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)[S](O)(=O)=O)c3O)[S](O)(=O)=O | InChi: | InChI=1S/C82H132O42S4/c1-97-3-5-99-7-9-101-11-13-103-15-17-105-19-21-107-23-25-109-27-29-111-31-33-113-35-37-115-39-41-117-43-45-119-47-49-121-51-53-123-81-71-55-67-59-75(125(85,86)87)61-69(79(67)83)57-73-65-78(128(94,95)96)66-74(58-70-62-76(126(88,89)90)60-68(80(70)84)56-72(81)64-77(63-71)127(91,92)93)82(73)124-54-52-122-50-48-120-46-44-118-42-40-116-38-36-114-34-32-112-30-28-110-26-24-108-22-20-106-18-16-104-14-12-102-10-8-100-6-4-98-2/h59-66,83-84H,3-58H2,1-2H3,(H,85,86,87)(H,88,89,90)(H,91,92,93)(H,94,95,96) | Definition date: | 2017-09-14 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 |
|
 | B4Z | Name: | ~{N}-[2-[(phenylmethyl)amino]ethyl]isoquinoline-5-sulfonamide | Formula: | C18 H19 N3 O2 S | SMILES: | O=[S](=O)(NCCNCc1ccccc1)c2cccc3cnccc23 | InChi: | InChI=1S/C18H19N3O2S/c22-24(23,18-8-4-7-16-14-19-10-9-17(16)18)21-12-11-20-13-15-5-2-1-3-6-15/h1-10,14,20-21H,11-13H2 | Definition date: | 2017-09-13 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | ~{N}-[2-[(phenylmethyl)amino]ethyl]isoquinoline-5-sulfonamide |
|
 | B5B | Name: | 1-(3-imidazol-1-ylpropyl)-5-(2-methylpropyl)-4-phenyl-imidazole | Formula: | C19 H24 N4 | SMILES: | CC(C)Cc1n(CCCn2ccnc2)cnc1c3ccccc3 | InChi: | InChI=1S/C19H24N4/c1-16(2)13-18-19(17-7-4-3-5-8-17)21-15-23(18)11-6-10-22-12-9-20-14-22/h3-5,7-9,12,14-16H,6,10-11,13H2,1-2H3 | Definition date: | 2017-09-13 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | 1-(3-imidazol-1-ylpropyl)-5-(2-methylpropyl)-4-phenyl-imidazole |
|
 | B8E | Name: | methyl 2-(5-methyl-2-phenyl-1,3-thiazol-4-yl)ethanoate | Formula: | C13 H13 N O2 S | SMILES: | COC(=O)Cc1nc(sc1C)c2ccccc2 | InChi: | InChI=1S/C13H13NO2S/c1-9-11(8-12(15)16-2)14-13(17-9)10-6-4-3-5-7-10/h3-7H,8H2,1-2H3 | Definition date: | 2017-09-22 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | methyl 2-(5-methyl-2-phenyl-1,3-thiazol-4-yl)ethanoate |
|
 | BFK | Name: | [3-[[5-methyl-2-[[3-(4-methylpiperazin-1-yl)-5-methylsulfonyl-phenyl]amino]pyrimidin-4-yl]amino]phenyl]methanol | Formula: | C24 H30 N6 O3 S | SMILES: | CN1CCN(CC1)c2cc(Nc3ncc(C)c(Nc4cccc(CO)c4)n3)cc(c2)[S](C)(=O)=O | InChi: | InChI=1S/C24H30N6O3S/c1-17-15-25-24(28-23(17)26-19-6-4-5-18(11-19)16-31)27-20-12-21(14-22(13-20)34(3,32)33)30-9-7-29(2)8-10-30/h4-6,11-15,31H,7-10,16H2,1-3H3,(H2,25,26,27,28) | Definition date: | 2017-09-29 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | [3-[[5-methyl-2-[[3-(4-methylpiperazin-1-yl)-5-methylsulfonyl-phenyl]amino]pyrimidin-4-yl]amino]phenyl]methanol |
|
 | CJK | Name: | 1-[(4-methylphenyl)methyl]-3-(2-oxidanyl-5-sulfamoyl-phenyl)urea | Formula: | C15 H17 N3 O4 S | SMILES: | Cc1ccc(CNC(=O)Nc2cc(ccc2O)[S](N)(=O)=O)cc1 | InChi: | InChI=1S/C15H17N3O4S/c1-10-2-4-11(5-3-10)9-17-15(20)18-13-8-12(23(16,21)22)6-7-14(13)19/h2-8,19H,9H2,1H3,(H2,16,21,22)(H2,17,18,20) | Definition date: | 2017-11-28 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | 1-[(4-methylphenyl)methyl]-3-(2-oxidanyl-5-sulfamoyl-phenyl)urea |
|
 | P71 | Name: | (2E)-2-{[(Z)-{3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4(1H)-ylidene}methyl]imino}-3-phenylpropanoic acid | Formula: | C17 H19 N2 O7 P | SMILES: | C(C(=NC=C1C(=CNC(=C1O)C)COP(=O)(O)O)Cc2ccccc2)(O)=O | InChi: | InChI=1S/C17H19N2O7P/c1-11-16(20)14(13(8-18-11)10-26-27(23,24)25)9-19-15(17(21)22)7-12-5-3-2-4-6-12/h2-6,8-9,18,20H,7,10H2,1H3,(H,21,22)(H2,23,24,25)/b14-9-,19-15+ | Definition date: | 2018-06-22 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | (2E)-2-{[(Z)-{3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4(1H)-ylidene}methyl]imino}-3-phenylpropanoic acid |
|
 | CXJ | Name: | (2S)-(3,5-difluorophenyl)(hydroxy)acetic acid | Formula: | C8 H6 F2 O3 | SMILES: | c1c(cc(F)cc1C(C(O)=O)O)F | InChi: | InChI=1S/C8H6F2O3/c9-5-1-4(2-6(10)3-5)7(11)8(12)13/h1-3,7,11H,(H,12,13)/t7-/m0/s1 | Definition date: | 2017-10-05 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | (2S)-(3,5-difluorophenyl)(hydroxy)acetic acid |
|
 | D0G | Name: | (14S)-14-methylhexadecanoic acid | Formula: | C17 H34 O2 | SMILES: | C(CCCCCCCCCCC(C)CC)CC(O)=O | InChi: | InChI=1S/C17H34O2/c1-3-16(2)14-12-10-8-6-4-5-7-9-11-13-15-17(18)19/h16H,3-15H2,1-2H3,(H,18,19)/t16-/m0/s1 | Definition date: | 2017-10-11 | Last modified: | 2018-10-05 | Release date: | 2018-10-10 | Identifier: | (14S)-14-methylhexadecanoic acid |
|